The European project IN-ARMOR, focused on advancing innovative strategies to combat antimicrobial resistance (AMR), held its 3rd Consortium Meeting in Biot (France), at the Sophia Antipolis Bioparc. The event brought together project partners from across Europe to review progress, align objectives, and strengthen collaboration towards achieving the project’s ambitious goals.
Leitat was proudly represented by Mònica Maijó Ferré and Jorge Galino from the Health and Biomedicine Area, who actively contributed to discussions on the scientific and technological developments carried out within the consortium.
The first day of the meeting was dedicated to the technical work packages, where partners presented the latest research results and shared valuable insights into ongoing R&D activities. The sessions provided a platform to assess achievements to date and to define the next steps in developing innovative antimicrobial coatings and materials designed to prevent infections and limit the spread of resistant microorganisms.
The second day focused on the long-term impact and sustainability of the project. Discussions addressed critical aspects such as:
Regulatory and ethical considerations to ensure compliance with European standards,
Communication, dissemination, and exploitation strategies to maximise the visibility and potential uptake of project results,
Risk management and contingency planning to safeguard the project’s objectives.
Beyond the technical sessions, participants had the opportunity to engage in networking activities, including a guided visit to the historic town of Antibes and a tour of the facilities of project partner Nuvisan, which offered valuable perspectives on translating scientific research into practical industrial applications.
Through initiatives like IN-ARMOR, Leitat reaffirms its commitment to advancing health innovation and supporting European efforts to address the global challenge of antimicrobial resistance. The consortium’s collaborative work continues to pave the way for new solutions that can contribute to safer healthcare environments and improved patient outcomes.
Leitat thanks all partners for their collaboration and contributions to the progress of IN-ARMOR.
